Market Overview:

Market Research Future (MRFR) reports that the U.S. Direct Anterior Approach Market Size is deemed to surpass a valuation of USD 2.52 Billion during the forecast period (2023-2032).

The U.S. direct anterior hip approach market has witnessed significant growth in recent years, driven by a rising preference for minimally invasive surgical techniques among both patients and surgeons. This approach, often referred to as the direct anterior approach (DAA), involves accessing the hip joint from the front of the body, allowing surgeons to operate with less disruption to surrounding muscles and tissues compared to traditional hip replacement methods. As a result, patients may experience faster recovery times, reduced post-operative pain, and improved mobility. This approach has gained popularity due to its potential to minimize tissue damage, leading to shorter hospital stays and decreased rehabilitation periods, which can contribute to overall cost savings for the healthcare system.

Additionally, technological advancements in surgical instruments and imaging techniques have further facilitated the adoption of the direct anterior hip approach in the U.S. market. Surgeons are increasingly utilizing specialized equipment designed specifically for DAA procedures, such as custom retractors and fluoroscopy systems, to enhance surgical precision and patient outcomes. Moreover, the growing aging population in the United States, coupled with an increasing prevalence of hip-related conditions such as osteoarthritis, continues to drive demand for hip replacement surgeries, further fueling the growth of the direct anterior approach market. As both patients and healthcare providers increasingly recognize the benefits of minimally invasive techniques like the direct anterior approach, the market is expected to continue its expansion in the foreseeable future.

Segmental Analysis

According to the extensive report, the U.S. Direct Anterior Approach Market \ in ambulatory surgical centers (ASC) market is segmented on the basis of U.S. total hip replacement, U.S. total hip replacement by direct anterior approach (DAA), and U.S. total hip replacement for DAA in ASC.  The U.S. Total Hip Replacement by DAA segment is booming aggressively as this form of surgery reduces recovery time resulting in decreased hospital stay, and less scarring is observed. It can touch a valuation of USD 4,926.5 million by 2023, growing at a 6.1% CAGR during the forecast period.

Competitive Dashboard

Prominent U.S. Direct Anterior Approach Companies are

Proliance Surgeons, OrthAlign, Inc., Smith & Nephew, Zimmer Biomet, Stryker, Orthoillinois, Bone & Joint Surgery Clinic, Centre for Special Surgery, The Hip and knee center, and Johnson & Johnson Services Inc. (DePuy Synthes), and others.

Regional Outlook

The U.S. Direct Anterior Approach Market Outlook has been on an upward trajectory owing to rising demand for minimally invasive procedures. The associated advantages with minimally invasive surgeries can boost market growth during the forecast period in the United States. Moreover, key manufacturers are focusing on technological advances and are striving to expand their geographical outreach to strengthen their market position.

Continuous innovation is one of the aspects these players are leveraging for competitive gains, leading to the scaling of the market in the U.S. In addition, increasing incidence of injuries and rising cases of obesity can fuel market growth. The presence of high-quality healthcare system has been paramount in boosting the market in the region. Product launches by key manufacturers are keeping the market afloat. For instance, in June 2018, OrthoGrid Systems launched HipGrid NINE for outpatient total hip replacement, which enables greater utility for C-arm imaging systems often found in ambulatory surgery centers and hospitals.     

Related Reports-

Bulimia Nervosa

Cardiovascular Application

Apheresis

us regenerative medicine

Pacemaker        

For more information, Please Visit us @ Market Research Future